Subscribe now

TODAY or tomorrow, a five-year-old child in a slum in Kenya will die
painfully of dysentery. This is not unusual. A thousand children in the world
die like this every day. And the toll is rising now that three-quarters of
the Shigella bacteria that cause dysentery resist treatment with old
antibiotics like ampicillin.

Yet over in neighbouring Uganda, amid similar poverty, another five-year-old
will get dysentery and survive. The difference: ciprofloxacin, a relatively new
antibiotic that still kills Shigella. In Uganda this lifesaver sells
for just seven cents a tablet. In Kenya, each pill costs $2.42, putting a
course of…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers


Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop